303 related articles for article (PubMed ID: 23545318)
1. Validation of minor stroke definitions for thrombolysis decision making.
Park TH; Hong KS; Choi JC; Song P; Lee JS; Lee J; Park JM; Kang K; Lee KB; Cho YJ; Saposnik G; Han MK; Bae HJ
J Stroke Cerebrovasc Dis; 2013 May; 22(4):482-90. PubMed ID: 23545318
[TBL] [Abstract][Full Text] [Related]
2. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
[TBL] [Abstract][Full Text] [Related]
3. Utility of Items of Baseline National Institutes of Health Stroke Scale as Predictors of Functional Outcomes at Three Months after Mild Ischemic Stroke.
Choi JC; Kim BJ; Han MK; Lee SJ; Kang K; Park JM; Park SS; Park TH; Cho YJ; Hong KS; Lee KB; Lee J; Ryu WS; Kim DE; Nah HW; Kim DH; Cha JK; Kim JT; Choi KH; Oh MS; Yu KH; Lee BC; Jang MS; Lee JS; Lee J; Bae HJ;
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1306-1313. PubMed ID: 28318959
[TBL] [Abstract][Full Text] [Related]
4. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
[TBL] [Abstract][Full Text] [Related]
5. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
Saposnik G; Demchuk A; Tu JV; Johnston SC;
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
[TBL] [Abstract][Full Text] [Related]
6. Recovery after ischemic stroke: criteria for good outcome by level of disability at day 7.
Hallevi H; Albright KC; Martin-Schild SB; Barreto AD; Morales MM; Bornstein N; Ifejika NL; Shuaib A; Grotta JC; Savitz SI;
Cerebrovasc Dis; 2009; 28(4):341-8. PubMed ID: 19628935
[TBL] [Abstract][Full Text] [Related]
7. Safety and outcome after thrombolysis in stroke patients with mild symptoms.
Köhrmann M; Nowe T; Huttner HB; Engelhorn T; Struffert T; Kollmar R; Saake M; Doerfler A; Schwab S; Schellinger PD
Cerebrovasc Dis; 2009; 27(2):160-6. PubMed ID: 19092237
[TBL] [Abstract][Full Text] [Related]
8. Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke scale score during 1-h recombinant tissue-type plasminogen activator infusion.
Osaki M; Miyashita F; Koga M; Fukuda M; Shigehatake Y; Nagatsuka K; Minematsu K; Toyoda K
Eur J Neurol; 2014 Mar; 21(3):411-8. PubMed ID: 24200315
[TBL] [Abstract][Full Text] [Related]
9. Rapidly improving stroke symptoms: a pilot, prospective study.
Balucani C; Bianchi R; Ramkishun C; Weedon J; Law S; Szarek M; Rojas-Soto D; Tariq S; Levine SR
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1211-6. PubMed ID: 25869774
[TBL] [Abstract][Full Text] [Related]
10. NIHSS-time score easily predicts outcomes in rt-PA patients: the SAMURAI rt-PA registry.
Aoki J; Kimura K; Koga M; Kario K; Nakagawara J; Furui E; Shiokawa Y; Hasegawa Y; Okuda S; Yamagami H; Okada Y; Shibazaki K; Sakamoto Y; Toyoda K
J Neurol Sci; 2013 Apr; 327(1-2):6-11. PubMed ID: 23433814
[TBL] [Abstract][Full Text] [Related]
11. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
[TBL] [Abstract][Full Text] [Related]
12. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
[TBL] [Abstract][Full Text] [Related]
13. Off-label thrombolysis for acute ischemic stroke: rate, clinical outcome and safety are influenced by the definition of 'minor stroke'.
Breuer L; Blinzler C; Huttner HB; Kiphuth IC; Schwab S; Köhrmann M
Cerebrovasc Dis; 2011; 32(2):177-85. PubMed ID: 21849777
[TBL] [Abstract][Full Text] [Related]
14. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
15. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
[TBL] [Abstract][Full Text] [Related]
16. Defining minor symptoms in acute ischemic stroke.
Strambo D; Zambon AA; Roveri L; Giacalone G; Di Maggio G; Peruzzotti-Jametti L; La Gioia S; Galantucci S; Comi G; Sessa M
Cerebrovasc Dis; 2015; 39(3-4):209-15. PubMed ID: 25791530
[TBL] [Abstract][Full Text] [Related]
17. Prediction of long-term outcome by percent improvement after the first day of thrombolytic treatment in stroke patients.
Nam HS; Lee KY; Han SW; Kim SH; Lee JY; Ahn SH; Kim DJ; Kim DI; Nam CM; Heo JH
J Neurol Sci; 2009 Jun; 281(1-2):69-73. PubMed ID: 19304298
[TBL] [Abstract][Full Text] [Related]
18. Outcome of ischemic stroke patients with serious post-thrombolysis neurological deficits.
Strbian D; Atula S; Meretoja A; Kaste M; Tatlisumak T;
Acta Neurol Scand; 2013 Apr; 127(4):221-6. PubMed ID: 22762436
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
Seet RC; Rabinstein AA
Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
[TBL] [Abstract][Full Text] [Related]
20. Percent change on the National Institutes of Health Stroke Scale: a useful acute stroke outcome measure.
Bruno A; Saha C; Williams LS
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):56-9. PubMed ID: 19110146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
